S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)

Cocrystal Pharma - COCP Earnings Date, Estimates & Call Transcripts

$0.41
-0.02 (-4.68%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.40
$0.43
50-Day Range
$0.38
$0.44
52-Week Range
$0.35
$1.23
Volume
177,537 shs
Average Volume
294,893 shs
Market Capitalization
$39.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.50

Earnings Summary

Upcoming
Earnings Date
Aug. 15Estimated
Actual EPS
(May. 11)
-$0.04
Consensus EPS
(May. 11)
-$0.04
Last Year's Q2 EPS
(5/16/2021)
-$0.04
Skip Charts & View Estimated and Actual Earnings Data

COCP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

COCP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cocrystal Pharma Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20221($0.04)($0.04)($0.04)

COCP Earnings Date and Information

Cocrystal Pharma last released its earnings results on May 11th, 2022. The reported ($0.04) EPS for the quarter, hitting analysts' consensus estimates of ($0.04). Cocrystal Pharma has generated ($0.16) earnings per share over the last year (($0.16) diluted earnings per share). Earnings for Cocrystal Pharma are expected to decrease in the coming year, from ($0.17) to ($0.18) per share. Cocrystal Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 15th, 2022 based off prior year's report dates.

Cocrystal Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/15/2022
(Estimated)
        
5/11/2022Q1 2022($0.04)($0.04)($0.04)
3/23/2022Q4 2021($0.04)($0.04)($0.04)
11/15/20219/30/2021($0.04)($0.04)($0.04)
8/15/20216/30/2021($0.04)($0.04)($0.04)
5/16/20213/31/2021($0.04)($0.04)($0.04)
3/16/2021Q4($0.04)($0.01)+$0.03($0.01)$0.58 million$0.51 million
11/16/2020Q3 2020($0.05)($0.05)($0.05)$0.45 million$0.49 million
11/16/2020Q3 2020($0.05)($0.05)($0.05)$0.45 million$0.49 million
8/6/2020Q2 2020($0.04)($0.07)($0.03)($0.07)$0.45 million$0.55 million
8/6/2020Q2 2020($0.04)($0.07)($0.03)($0.07)$0.45 million$0.55 million
8/6/2020Q2 2020($0.04)($0.07)($0.03)($0.07)$0.45 million$0.55 million
5/14/2020Q1 2020($0.05)($0.05)($0.05)$0.46 million
5/14/2020Q1 2020($0.05)($0.05)($0.05)$0.46 million
5/14/2020Q1 2020($0.08)($0.05)+$0.03($0.05)$0.46 million
3/27/2020Q4 2019($0.05)($0.05)$1.40$0.40 million
3/27/2020Q4 2019($0.05)($0.05)$1.40$0.40 million
3/27/2020Q4 2019($0.05)($0.05)$1.40$0.40 million
11/12/2019Q3 2019($0.06)($0.06)($0.06)$0.49 million
11/12/2019Q3 2019($0.06)($0.06)($0.06)$0.49 million
11/12/2019Q3 2019($0.08)($0.06)+$0.02($0.06)$0.49 million
8/9/2019Q2 2019($0.05)($0.05)($0.05)$0.59 million
8/9/2019Q2 2019($0.05)($0.05)($0.05)$0.59 million
8/9/2019Q2 2019($0.05)($0.05)($0.05)$0.59 million
5/10/2019Q1 2019$0.10+$0.10$0.10$5.08 million
5/10/2019Q1 2019$0.10+$0.10$0.10$5.08 million
5/10/2019Q1 2019$0.10+$0.10$0.10$5.08 million
11/12/2018Q3 2018($0.06)($0.06)($0.06)
11/12/2018Q3 2018($0.06)($0.06)($0.06)
11/12/2018Q3($0.08)($0.06)+$0.02($0.06)
8/9/2018Q2 2018($0.05)($0.05)($0.05)
8/9/2018Q2 2018($0.05)($0.05)($0.05)
8/9/2018Q2 2018($0.05)($0.05)($0.05)
5/11/2018Q1 2018($0.06)($0.06)($0.06)
5/11/2018Q1 2018($0.06)($0.06)($0.06)
5/11/2018Q1 2018($0.06)($0.06)($0.06)
3/22/2018Q4 2017$0.20+$0.20$0.20
3/22/2018Q4 2017$0.20+$0.20$0.20
3/22/2018Q4 2017$0.20+$0.20$0.20












Cocrystal Pharma Earnings - Frequently Asked Questions

When is Cocrystal Pharma's earnings date?

Cocrystal Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 15th, 2022 based off last year's report dates. Learn more on COCP's earnings history.

Did Cocrystal Pharma beat their earnings estimates last quarter?

In the previous quarter, Cocrystal Pharma (NASDAQ:COCP) reported ($0.04) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.04). Learn more on analysts' earnings estimate vs. COCP's actual earnings.

How much revenue does Cocrystal Pharma generate each year?

Cocrystal Pharma (NASDAQ:COCP) has a recorded annual revenue of $2.01 million.

How much profit does Cocrystal Pharma generate each year?

Cocrystal Pharma (NASDAQ:COCP) has a recorded net income of -$14.19 million. COCP has generated -$0.16 earnings per share over the last four quarters.

What is Cocrystal Pharma's EPS forecast for next year?

Cocrystal Pharma's earnings are expected to decrease from ($0.17) per share to ($0.18) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:COCP) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.